Google takes on Apple’s Contact Poster with new ‘Calling Cards’ feature Apple introduced the Contact Poster feature in iOS 17 for users who were complaining about their blank incoming call screens.

PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.25.

PDS Biotechnology Corp (PDSB), a clinical-stage biotech company with a market capitalization of $57.7 million, reported a net loss of $8.5 million, or $0.21 per share, for the first quarter of 2025, ...

CyberArk Software Ltd. (NASDAQ:CYBR) Q1 2025 Earnings Call Transcript May 13, 2025 CyberArk Software Ltd. beats earnings expectations. Reported EPS is $0.98, expectations were $0.79. Operator ...

PDS Biotechnology Corp (PDSB), a clinical-stage biotech company with a market capitalization of $57.7 million, reported a net loss of $8.5 million, or $0.21 per share, for the first quarter of ...

CyberArk Software Ltd. (NASDAQ:CYBR) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany Participants. Srinivas Anantha - Vice President, Investor Relations Matt Cohen - Chief ...

PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results Provided by GlobeNewswire May 7, 2025, 12:00:00 PM.

PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the ...

PDS Biotechnology Corp (PDSB) reported a net loss of $37.6 million for 2024, an improvement from the $42.9 million loss in 2023, during its Q4 2024 earnings call. The company’s efforts to reduce ...

After the live webcast, the event will be archived on PDS Biotech’s website for six months. About PDS Biotechnology PDS Biotechnology is a late-stage immunotherapy company focused on ...

Experts call for a shift in PDS; suggest including millets for nutritional security and cost saving Research by the Tata-Cornell Institute (TCI) reveals that the true cost of the PDS in 2021-22 ...

--PDS Biotechnology Corporation, a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the Company will host a conference ...